Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 1 1

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 2Breast 1

Conditions

Brain Neoplasms 2Postoperative Nausea and Vomiting 1Pain, Postoperative 1Pain 1Intracranial Aneurysm 1Hyperalgesia 1Fibrosis 1Diabetes Mellitus 1Breast Neoplasms 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × esmolol × Clear all
NCT05769868 2024-10-01

CIBERbBECHO

Consorcio Centro de Investigación Biomédica en Red (CIBER)

Phase 3 Recruiting
1,000 enrolled

Diabetes Mellitus, Fibrosis

NCT01544959 2018-10-24

PAINFree

Université de Sherbrooke

Phase NA Completed
84 enrolled
Breast

Breast Neoplasms, Hyperalgesia, Pain, Pain, Postoperative, Postoperative Nausea and Vomiting

NCT02563288 2017-07-27

Esmolol Versus Dexmedetomidine During Intracranial Procedures

George Papanicolaou Hospital

Phase 3 Unknown
60 enrolled
CNS

Brain Neoplasms, Intracranial Aneurysm

NCT01951950 2014-08-29

Nicardipine vs Esmolol Craniotomy Emergence

Northwestern University

Phase 1 Completed
40 enrolled 6 charts
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡